Effect of corticosteroid (CS) use at baseline (CUB) on overall survival (OS) in patients (pts) receiving abiraterone acetate (AA): Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D) Meeting Abstract
| Authors: | Montgomery, R. B.; San Kheoh, T.; Molina, A.; Li, J.; Bellmunt, J.; Ryan, C. J.; Tran, N.; Loriot, Y.; Efstathiou, E.; Scher, H. I.; De Bono, J. S. |
| Abstract Title: | Effect of corticosteroid (CS) use at baseline (CUB) on overall survival (OS) in patients (pts) receiving abiraterone acetate (AA): Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601615 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.5014 |
| Notes: | Meeting Abstract: 5014 -- Source: Wos |
